Enhanced Methods and Apparatuses for Reducing Bleeding via Coordinated Trigeminal and Vagal Nerve Stimulation

Improved systems and methods for reducing bleeding in patients by simultaneously stimulating the trigeminal and vagal nerves, incorporating real-time feedback mechanisms and advanced sensor technologies to enhance treatment efficacy and safety.

The original patent disclosed methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation. However, the existing patent had limitations in terms of adjusting stimulation intensity in real-time, remote monitoring, and power source lifespan. The new inventive concept addresses these limitations by introducing advanced sensor technologies, real-time feedback mechanisms, and miniaturized stimulators with extended power sources.

The enhanced system for reducing bleeding in patients comprises a neural stimulator configured to simultaneously stimulate the trigeminal and vagal nerves, and a sensor for detecting blood coagulation levels. The neural stimulator adjusts the stimulation intensity based on the detected blood coagulation levels, ensuring optimal treatment efficacy. Additionally, the system includes a wearable device and a mobile application for remotely monitoring and adjusting the stimulation intensity. The neural stimulation device features a miniaturized stimulator and an extended lifespan power source, enhancing user convenience and reducing maintenance requirements.

The new claims introduce the concept of real-time feedback mechanisms, advanced sensor technologies, and miniaturized stimulators with extended power sources, which are not present in the original patent. These advancements provide a significant improvement in treatment efficacy, safety, and user convenience, thereby constituting a novel and non-obvious inventive step.

Alternative embodiments of the inventive concept may include the use of different sensor technologies, such as optical or acoustic sensors, to detect blood coagulation levels. Additionally, the system could be adapted for use in various medical procedures, such as surgical interventions or trauma care, or integrated with other medical devices, such as patient monitoring systems.

The enhanced system for reducing bleeding in patients has significant commercial potential in the medical device industry, particularly in the areas of surgical interventions, trauma care, and patient monitoring. The target market includes hospitals, clinics, and medical research institutions, with potential for expansion into the consumer market for personal health monitoring and emergency response applications.